中国中药杂志

2020, v.45(19) 4798-4804

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

海桐皮的本草考证
Herbal textual research on Cortex Erythrinae

孟武威;詹志来;
MENG Wu-wei;ZHAN Zhi-lai;Bozhou Jingwan Chinese Herbal Medicine Factory;National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences;

摘要(Abstract):

历代本草关于海桐皮的植物来源记载较多,且描述较简,加之各地习用品较多,导致海桐皮商品较为混乱,有必要开展深入的本草考证,正本清源,规范海桐皮用药。该文对历代本草所记载的海桐皮,按照植物的形态特征、产地、生境、药图、功效进行详细考证分析,得出历代本草中所载的正品海桐皮应为木棉科木棉Bombax malabaricum的干燥树皮,即为现广东省地方标准所收载并至今沿用的广海桐皮。而《中国药典》1977年版所收载的豆科刺桐Erythrina varlegata var.orientalis.或乔木刺桐E.arborescens的干燥树皮在古代应为刺桐。该文通过对海桐皮历代基原变迁、产地变迁、品质评价进行了系统详细总结,为海桐皮的正确用药和资源的进一步开发利用提供依据。
There are many records about the plant origin of Cortex Erythrinae in the past dynasties, but the descriptions were simple and there are many varieties used in different places, which leads to the confusion of Cortex Erythrinae commodities.It is necessary to make a thorough textual research on this herb to get the accurate origin and standardize the use of Cortex Erythrinae. In this paper, according to the plant morphological characteristics, producing areas, habitat, attached drawings of medicinal materials and efficacy, we have made a detailed research on Cortex Erythrinae recorded in the past dynasties. It is concluded that the authentic Cortex Erythrinae contained in the past dynasties should be the dry bark of Bombax malabaricum, which also named as Guanghaitongpi collected in the current local standards of Guangdong province and it is still in use today.The dry bark of Erythrina varlegata var. orientalis and E. arborescens recorded in Chinese Pharmacopoeia in 1977 should be "Citong" in ancient times. In this paper, based on the systematic and detailed summary of the origin changes, producing area changes and quality evaluation of Cortex Erythrinae, the basis for the correct use of Cortex Erythrinae and the further development and utilization of resources was provided.

关键词(KeyWords): 海桐皮;本草考证;基原;品质评价
Cortex Erythrinae;herbal textual;origin;quality evaluation

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划项目(2019YFC1711401,2017YFC1700805);; 中央本级重大增减支项目(2060302);; 中国中医科学院基本科研业务费专项(ZZ13-YQ-091)

作者(Author): 孟武威;詹志来;
MENG Wu-wei;ZHAN Zhi-lai;Bozhou Jingwan Chinese Herbal Medicine Factory;National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences;

Email:

DOI: 10.19540/j.cnki.cjcmm.20200627.101

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享